KLRK1 and plasma cell myeloma: CS1-NKG2D BsAb activates the NKG2D–DAP10 complex on NK cells, thereby activating the phosphorylation of AKT to induce IFN-γ production and specific lysis of myeloma cells and significantly prolonging survival in mice (Chan et al., 2018).